Unibest
← Back to patent-cliff list

18-Methoxycoronaridine

Tier C — Watch / trade

18-Methoxycoronaridine

Savant Hwp
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:nAChRα3&β4

Indications (approved):利什曼原虫感染, Drug-related adverse effects and reactions, Opioid dependence

Regional status

US
-
EU
-
China
-
Japan
-

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 5 · Total yield 65 mg
18-MC-001—18-MC-002188125-30-618-MC-003341970-89-618-MC-004—18-MC-005—18-MC-006247088-80-818-MC-007—API · 18-Methoxycoronaridine
CodeCAS No.Intermediate
18-MC-001-methyl 3-((R)-1-(naphthalen-1-yl)ethyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole-5-carboxylate
18-MC-002188125-30-64-(1,3-dioxolan-2-yl)-6-methoxyhexanal
18-MC-003341970-89-6methyl (3aS,4R,11bR)-4-(2-(1,3-dioxolan-2-yl)-4-methoxybutyl)-3-((R)-1-(naphthalen-1-yl)ethyl)-2,3,3a,4,5,7-hexahydro-1H-pyrrolo[2,3-d]carbazole-6-carboxylate
18-MC-004-methyl (3aR,4S,11bS)-4-(2-(1,3-dioxolan-2-yl)-4-methoxybutyl)-3-((R)-1-(naphthalen-1-yl)ethyl)-2,3,3a,4,5,7-hexahydro-1H-pyrrolo[2,3-d]carbazole-6-carboxylate
18-MC-005-methyl 5-(2-(1,3-dioxolan-2-yl)-4-methoxybutyl)-3-((R)-1-(naphthalen-1-yl)ethyl)-1,2,3,4,5,6,7,8-octahydroazonino[5,4-b]indole-7-carboxylate
18-MC-006247088-80-8methyl (5R,7R)-5-(2-(1,3-dioxolan-2-yl)-4-methoxybutyl)-1,2,3,4,5,6,7,8-octahydroazonino[5,4-b]indole-7-carboxylate
18-MC-007-methyl (7S,9R)-5-(2-methoxyethyl)-1,6,7,8,9,10-hexahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indole-9-carboxylate
OptimisedRoute 2Steps 3 · Total yield 0.51 g
18-MC-008—18-MC-009—18-MC-010341970-92-118-MC-011188125-38-4API · 18-Methoxycoronaridine
CodeCAS No.Intermediate
18-MC-008--
18-MC-009--
18-MC-010341970-92-1methyl (3aS,4R,11bR)-4-(2-(1,3-dioxolan-2-yl)-4-methoxybutyl)-2,3,3a,4,5,7-hexahydro-1H-pyrrolo[2,3-d]carbazole-6-carboxylate
18-MC-011188125-38-4methyl (3aS,4R,11bR)-4-(2-(1,3-dioxolan-2-yl)-4-methoxybutyl)-3-benzyl-2,3,3a,4,5,7-hexahydro-1H-pyrrolo[2,3-d]carbazole-6-carboxylate

Frequently asked questions

What are the approved indications of 18-Methoxycoronaridine?

Approved indications include: 利什曼原虫感染, Drug-related adverse effects and reactions, Opioid dependence.

When does the 18-Methoxycoronaridine patent expire?

No public expiry year is available for 18-Methoxycoronaridine yet; this page updates once verified.

How many synthesis routes are recorded for 18-Methoxycoronaridine?

2 synthesis routes are recorded; the shortest is 3 steps with 0.51 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy 18-Methoxycoronaridine intermediates?

All intermediates in 18-Methoxycoronaridine routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for 18-Methoxycoronaridine intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-06